The company also announced the appointment of its current Executive Chair, Alvin Shih, MD to the Chief Executive Officer role, plus the appointment of Rebecca Luse, Managing Director at Deep Track ...

Heart failure with preserved ejection fraction (HFpEF) is a disease in which the left ventricle (LV) of the heart shows impaired relaxation during cardiac diastole, often accompanied by structural and ...

The findings from this single-center retrospective study compare outcomes between 2 groups of patients living with connective ...

In this video, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, discusses notable updates across several areas of cardiology ...

Corvista Health’s point-of-care device, used to predict pulmonary hypertension (PH), also appears to work well at identifying ...

Cardiac illnesses are among the trickier ones to manage in the limited time provided for many primary care visits, with ...

Findings presented at the American College of Cardiology Annual Scientific Session indicate that finerenone's efficacy in ...

It's especially vital for spotting Heart Failure with preserved Ejection Fraction (HFpEF) - now over half of all heart failure cases - and for monitoring cardiotoxicity in ocology patients undergoing ...

Severity of cardiometabolic comorbidity burden affects risk for all-cause hospitalization in patients with heart failure.

A team of scientists led by Northwestern Medicine investigators have uncovered new details about a deadly heart condition ...

A gene therapy for heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure, has shown ...

The HFpEF Summit is a biannual, two-day meeting bringing together internationally recognized leaders in the clinical, biological, and translational study of HFpEF. This summit focused on the latest ...